News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambridge Major Laboratories, Inc. Adds Significant Capacity at U.S. Site



9/10/2012 10:05:03 AM

GERMANTOWN, Wis.--(BUSINESS WIRE)--Following continued growth in demand for larger scale Active Pharmaceutical Ingredient (API) manufacturing services, Cambridge Major Laboratories (CML) is announcing a significant expansion of its large scale API manufacturing facility in Germantown, Wisconsin. The expansion comes only three years after commissioning the new state-of-the-art facility, further validating CML’s business model of focused investment in US-based assets.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES